Literature DB >> 22483676

Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01).

Tomas Kron1, Daniel Pham, Paul Roxby, Aldo Rolfo, Farshad Foroudi.   

Abstract

BACKGROUND: Daily variations in bladder filling make conformal treatment of bladder cancer challenging. On-line adaptive radiotherapy with a choice of plans has been demonstrated to reduce small bowel irradiation in single institution trials. In order to support a multicentre feasibility clinical trial on adaptive radiotherapy for bladder cancer (TROG 10.01) a credentialing programme was developed for centres wishing to participate.
METHODS: The credentialing programme entails three components: a facility questionnaire; a planning exercise which tests the ability of centres to create three adaptive plans based on a planning and five cone beam CTs; and a site visit during which image quality, imaging dose and image guidance procedures are assessed. Image quality and decision making were tested using customised inserts for a Perspex phantom (Modus QUASAR) that mimic different bladder sizes. Dose was assessed in the same phantom using thermoluminescence dosimetry (TLD).
RESULTS: All 12 centres participating in the full credentialing programme were able to generate appropriate target volumes in the planning exercise and identify the correct target volume and position the bladder phantom in the phantom within 3mm accuracy. None of the imaging doses exceeded the limit of 5 cGy with a CT on rails system having the lowest overall dose.
CONCLUSION: A phantom mimicking the decision making process for adaptive radiotherapy was found to be well suited during site visits for credentialing of centres participating in a clinical trial of adaptive radiotherapy for bladder cancer. Combined with a planning exercise the site visit allowed testing the ability of centres to create adaptive treatment plans and make appropriate decisions based on the volumetric images acquired at treatment.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22483676     DOI: 10.1016/j.radonc.2012.03.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer.

Authors:  Tomas Kron; Brent Chesson; Nicholas Hardcastle; Melissa Crain; Natalie Clements; Mark Burns; David Ball
Journal:  Br J Radiol       Date:  2018-03-06       Impact factor: 3.039

2.  A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer.

Authors:  Janice Yeh; Mathias Bressel; Keen Hun Tai; Tomas Kron; Farshad Foroudi
Journal:  Clin Transl Radiat Oncol       Date:  2021-08-06

3.  A multi-national report on methods for institutional credentialing for spine radiosurgery.

Authors:  Peter C Gerszten; Arjun Sahgal; Jason P Sheehan; Ronald Kersh; Stephanie Chen; John C Flickinger; Mubina Quader; Daniel Fahim; Inga Grills; John H Shin; Brian Winey; Kevin Oh; Reinhart A Sweeney; Matthias Guckenberger
Journal:  Radiat Oncol       Date:  2013-06-27       Impact factor: 3.481

4.  Dosimetric end-to-end tests in a national audit of 3D conformal radiotherapy.

Authors:  Joerg Lehmann; Andrew Alves; Leon Dunn; Maddison Shaw; John Kenny; Stephanie Keehan; Jeremy Supple; Francis Gibbons; Sophie Manktelow; Chris Oliver; Tomas Kron; Ivan Williams; Jessica Lye
Journal:  Phys Imaging Radiat Oncol       Date:  2018-04-24

5.  Pathway for radiation therapists online advanced adapter training and credentialing.

Authors:  Meegan Shepherd; Siobhan Graham; Amy Ward; Lissane Zwart; Bin Cai; Charlotte Shelley; Jeremy Booth
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2021-12-08

Review 6.  Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology.

Authors:  Carri K Glide-Hurst; Percy Lee; Adam D Yock; Jeffrey R Olsen; Minsong Cao; Farzan Siddiqui; William Parker; Anthony Doemer; Yi Rong; Amar U Kishan; Stanley H Benedict; X Allen Li; Beth A Erickson; Jason W Sohn; Ying Xiao; Evan Wuthrick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-24       Impact factor: 7.038

7.  Introduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (Trans-Tasman Radiation Oncology Group 10.01): Lessons learned.

Authors:  Daniel Pham; Paul Roxby; Tomas Kron; Aldo Rolfo; Farshad Foroudi
Journal:  J Med Phys       Date:  2013-04

8.  The role of medical physicists in clinical trials: More than quality assurance.

Authors:  Tomas Kron
Journal:  J Med Phys       Date:  2013-07

9.  Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module.

Authors:  Emma Patel; Yat Tsang; Angela Baker; Jenny Callender; Shaista Hafeez; Emma Hall; Vibeke Nordmark Hansen; Rebecca Lewis; Helen McNair; Elizabeth Miles; Robert Huddart
Journal:  Clin Transl Radiat Oncol       Date:  2019-07-24

10.  A new era for clinical trial quality assurance: A credentialing programme for RTT led adaptive radiotherapy.

Authors:  Yat Tsang; Angela Baker; Emma Patel; Elizabeth Miles
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2018-01-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.